Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RPL7P25 (Ribosomal protein L7 pseudogene 25)** is a processed pseudogene located in the human genome, derived from the ribosomal protein L7 (RPL7) gene. Unlike the protein-coding RPL7 gene, RPL7P25 does not encode a protein and has no known biological function, disease involvement, or relevance as a therapeutic target. Processed pseudogenes such as RPL7P25 result from retrotransposition events and are typically non-functional, although they can sometimes be transcribed or exert regulatory effects, but no such activity is described for RPL7P25[4][6].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7 pseudogene 25 (RPL7P25).